FDA Seeking Input On Long-Term Follow-Up For HIV Entry Inhibitors

FDA and the Forum for Collaborative HIV Research will hold a public meeting on Jan. 18 to discuss the appropriate collection of long-term follow-up data for CCR5 antagonist clinical trials.